Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Does Government Involvement Make Pharmaceuticals More or Less Affordable to the End User?

Does Government Involvement Make Pharmaceuticals More or Less Affordable to the End User?

FromHealthcare Americana


Does Government Involvement Make Pharmaceuticals More or Less Affordable to the End User?

FromHealthcare Americana

ratings:
Length:
32 minutes
Released:
Aug 30, 2021
Format:
Podcast episode

Description

John Zevzavadjian, EVP of Enterprise Platform Solutions, has over 25 years of experience in healthcare and pharmacy management. In his previous role, he served as the SVP of Payer Relations where he led the strategy and execution of all Payer activities at CVS Pharmacy. During the episode, Zevzavadjian discusses the role and challenges of the U.S. government taking on more of the payer. Some of the challenges are the cost of new drugs and the balance around innovation. He says the government has a bias to do something, but he doesn’t see them taking over the total spend. Support the show (https://healthcareamericana.com/sponsors/)
Released:
Aug 30, 2021
Format:
Podcast episode

Titles in the series (100)

People are lost navigating healthcare. Doctors are forced to treat their patients like an assembly line. An emphasis on production works in a factory making widgets, but not with people. Direct Primary Care changes all of this.